A Comparison of Effectiveness of Sodium Bicarbonate in Patients Intoxicated by Tricyclic Antidepressants and Anticholinergic Drugs Other Than Tricyclic Antidepressants which Affected the Heart

被引:0
|
作者
Icme, Ferhat [1 ]
Kekec, Zeynep [2 ]
Sebe, Ahmet [2 ]
Seydaoglu, Gulsah [3 ]
Acikalin, Ayca [4 ]
Avci, Akkan [5 ]
机构
[1] Ankara Ataturk Egitim & Arastirma Hastanesi, Acil Serv, Ankara, Turkey
[2] Cukurova Univ, Tip Fak, Acil Tip AD, Adana, Turkey
[3] Cukurova Univ, Tip Fak, Biyoistat AD, Adana, Turkey
[4] Bakirkoy Dr Sadi Konuk Egitim & Arastirma Hastane, Acil Serv, Istanbul, Turkey
[5] Adana Numune Egitim & Arastirma Hastanesi, Acil Serv Klin, Adana, Turkey
来源
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI | 2012年 / 32卷 / 04期
关键词
Cholinergic antagonists; sodium bicarbonate; heart conduction system; poisoning; AMERICAN-ASSOCIATION;
D O I
10.5336/medsci.2011-24754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Anticholinergic drug poisoning is among the life threatening poisonings frequently seen in emergency services. These drugs have serious side effects on heart like heart rate alterations, arrhythmias and conduction delays. The purpose of our study is to determine whether the other negative impacts of intoxication with tricyclic antidepressants (TCA) and anticholinergic drugs other than TCAs on heart are similar in nature in patients with QTc >= 45, and to compare the effectiveness of the standard NaHCO3 treatment on prolongation of QTc as well as QRS complex widening in patients intoxicated by anticholinergic drugs. Material and Methods: This prospective case-control study was planned to enroll patients who admitted to emergency service of Cukurova University Medical Faculty between June 06, 2005 and November 30, 2006 due to poisoning with TCA or anticholinergic drugs other than TCAs, and having a QTc interval >= 0.45 on the electrocardiogram (ECG) taken at the time of admission. The patients were managed with a 2 rnEq/kg dose of NaHCO3 treatment. In both groups, changes in QTc and QRS distances, cardiac biochemical parameters and systolic blood pressure and heart rate changes were compared with respect to time and the groups. Biochemical parameters related to possible complications due to the given treatment were examined. Results: The patients' demographic, clinical, electrocardiographic and laboratory findings were recorded and analyzed. A total of 58 patients, 30 of whom were poisoned with TCA agents, and 28 were poisoned with other drugs with anticholinergic effects were enrolled in the study. All patients had prolonged QTc and tachycardia and in 64.9% of the patients (n=37) QRS was >= 0.1. When we compared the QRS and QTc values at admission and at the sixtieth minute of the therapy, we observed a statistically significant decrease in both groups. Hopwever this reduction did not differ significantly between the groups. No significant changes were observed in systolic blood pressures or cardiac biochemical parameters of the patients of during the time between admission and discharge. Treatment and follow-up of all patients were performed in the emergency observation unit. No mortality occurred among patients in both groups. Conclusion: The fact that NaHCO3 treatment completely improved signs and symptoms and no treatment-related complications like hypertension, metabolic alcalosis, hypernatremia, hypokalemia, hypocalcemia developed, we suppose that standard 2 meq/kg NaHCO3 treatment is valid, effective and reliable in anticholinergic drug poisonings.
引用
收藏
页码:938 / 945
页数:8
相关论文
共 33 条
  • [21] Assessing Prolongation of the Heart Rate Corrected QT Interval in Users of Tricyclic Antidepressants Advice to Use Fridericia Rather Than Bazett's Correction
    Noordam, Raymond
    van den Berg, Marten E.
    Niemeijer, Maartje N.
    Aarts, Nikkie
    Leening, Maarten J. G.
    Deckers, Jaap W.
    Hofman, Albert
    Rijnbeek, Peter R.
    Eijgelsheim, Mark
    Kors, Jan A.
    Stricker, Bruno H.
    Visser, Loes E.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (03) : 260 - 265
  • [22] Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: A clinical overview
    Amrein, R
    Stabl, M
    Henauer, S
    Affolter, E
    Jonkanski, I
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1997, 42 (10): : 1043 - 1050
  • [23] Comparison of effectiveness and side effects of selegiline transdermal system versus oral monoamine oxidase inhibitors and tricyclic antidepressants for treatment-resistant depression
    Kim, Thomas T.
    Xu, Colin
    Amsterdam, Jay D.
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 376 : 47 - 51
  • [24] MONOAMINE-OXIDASE INHIBITORS IN RESISTANT MAJOR DEPRESSION - A DOUBLE-BLIND COMPARISON OF BROFAROMINE AND TRANYLCYPROMINE IN PATIENTS RESISTANT TO TRICYCLIC ANTIDEPRESSANTS
    NOLEN, WA
    HAFFMANS, PMJ
    BOUVY, PF
    DUIVENVOORDEN, HJ
    JOURNAL OF AFFECTIVE DISORDERS, 1993, 28 (03) : 189 - 197
  • [25] Unexpected elevations of the AxSym® cardiac troponin I assay without increase of other cardiac markers in psychiatric patients treated with tricyclic antidepressants or Clozapine.
    Baum, H
    Steimer, W
    Neumeier, D
    CLINICAL CHEMISTRY, 1999, 45 (06) : A134 - A134
  • [26] A 1ST-ESTIMATION OF THE THERMODYNAMIC PARAMETERS OF WATER N-OCTANOL PARTITIONING OF SOME TRICYCLIC ANTIDEPRESSANTS - SIMILARITIES AND DIFFERENCES WITH THE VALUES OF OTHER PSYCHOTROPIC-DRUGS
    BURGOT, G
    BURGOT, JL
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 94 (1-3) : 135 - 142
  • [27] Differential effect of ayurveda (Indian traditional system of medicine) and tricyclic antidepressants in altering cardiac autonomic functions in patients of major depression - A clinical study with heart rate variability (HRV) measures
    Vishore, K. R.
    Udupa, K.
    Gangadhar, B. N.
    Lavekar, G. S.
    Raju, T. R.
    Sathyaprabha, T. N.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 : S70 - S70
  • [28] Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
    Kosiborod, Mikhail
    Cavender, Matthew A.
    Fu, Alex Z.
    Wilding, John P.
    Khunti, Kamlesh
    Holl, Reinhard W.
    Norhammar, Anna
    Birkeland, Kare I.
    Jorgensen, Marit Eika
    Thuresson, Marcus
    Arya, Niki
    Bodegard, Johan
    Hammar, Niklas
    Fenici, Peter
    CIRCULATION, 2017, 136 (03) : 249 - +
  • [29] Letter by Koh Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"
    Koh, Kwang Kon
    CIRCULATION, 2018, 137 (09) : 984 - +
  • [30] Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"
    Tampaki, Ekaterini Christina
    Tampakis, Athanasios
    Pantos, Costas
    CIRCULATION, 2018, 137 (09) : 982 - 983